CASE

To alleviate the blood shortage in Cameroon and improve the quality of local healthcare, the World Health Organization, in collaboration with ISDB Bank, has chosen Haier Biomedical to fund and purchase Haier Biomedical’s Blood Refrigerator HXC-106 and Haier Biomedical’s Plasma Freezer DW40-W100, a total of 196 units of Haier Biomedical products to help build the national blood transfusion centre and 4 regional blood transfusion centres in Cameroon. 

Haier Biomedical’s products now located at top research universities in the U.S. to assist in the development of anti-pandemic research and are trusted by U.S. government agencies as a long-term partner.

In recent years, biobanks have become increasingly important to scientific research, and many studies require the use of samples from biobanks to carry out their work. 

This is especially important in the context of the global COVID-19 pandemic, the safety of the samples and of the research personnel becomes the top priority. 

TUSEB ordered five YDD-750-445 liquid nitrogen containers from Haier Biomedical after a comparison process in order to improve the construction of a biobank and to achieve safe and efficient storage. 

To alleviate the blood shortage in Cameroon and improve the quality of local healthcare, the World Health Organization, in collaboration with ISDB Bank, has chosen Haier Biomedical to fund and purchase Haier Biomedical’s Blood Refrigerator HXC-106 and Haier Biomedical’s Plasma Freezer DW40-W100, a total of 196 units of Haier Biomedical products to help build the national blood transfusion centre and 4 regional blood transfusion centres in Cameroon. 

COVAX, known as the COVID-19 Vaccine Implementation Program, is co-led by the Coalition for Epidemic Prevention and Innovation (CEPI), the Vaccine Alliance (Gavi) and the World Health Organization (WHO) to ensure equitable access to the COVID-19 vaccine for all participating countries and economies.